Nora Cazzagon

Dr. Nora Cazzagon

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
WLWillem J Lammers
Willem J Lammers
HBHenk R Van Buuren
Henk R Van Buuren
GHGideon M Hirschfield
Gideon M Hirschfield
HJHarry L A Janssen
Harry L A Janssen
PIPietro Invernizzi
Pietro Invernizzi
GGGlobal PBC Study Group
Global PBC Study Group

9 May 2014 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
AFAnnarosa Floreani
Annarosa Floreani
IFIrene Franceschet
Irene Franceschet
NCNora Cazzagon
Nora Cazzagon
ASAlice Spinazzè
Alice Spinazzè
ABAlessandra Buja
Alessandra Buja
MGM. Eric Gershwin
M. Eric Gershwin

28 June 2022 in Journal of Hepatology
Verified
Journal Article
Closed access
CCChristophe Corpechot
Christophe Corpechot
FCFabrice Carrat
Fabrice Carrat
FGFarid Gaouar
Farid Gaouar
FCFrederic Chau
Frederic Chau
GHGideon Hirschfield
Gideon Hirschfield
VLVictor de Lédinghen
Victor de Lédinghen

1 June 2021 in Pathologica
Verified
Journal Article
Open access
PDF file
SSSamantha Sarcognato
Samantha Sarcognato
DSDiana Sacchi
Diana Sacchi
FGFederica Grillo
Federica Grillo
NCNora Cazzagon
Nora Cazzagon
LFLuca Fabris
Luca Fabris
MGMaria Guido
Maria Guido
Autoimmune cholestatic liver diseases are rare hepato-biliary disorders characterized by a progressive, inflammatory destruction of bile ducts. Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are the main autoimmune cholestatic liver diseases. Both may evolve into secondary biliary cirrhosis and its complications. Therapeutic options are limited and liver transplantation remains the only definitive treatment for PBC and PSC. Most PBC and PSC patients have a typical presentation, which does not require liver biopsy. However, in routine clinical practice, important variants or specific subgroups that benefit from liver biopsy for proper management may be observed. Herein, we provide a general overview of clinical and pathological characteristic of PBC and PSC, highlighting the most important features for routine diagnostic practice.

1 June 2021 in Pathologica
Verified
Journal Article
Open access
PDF file
CCClaudia Covelli
Claudia Covelli
DSDiana Sacchi
Diana Sacchi
SSSamantha Sarcognato
Samantha Sarcognato
NCNora Cazzagon
Nora Cazzagon
FGFederica Grillo
Federica Grillo
MGMaria Guido
Maria Guido
Autoimmune hepatitis (AIH) is a relatively rare non-resolving chronic liver disease, which mainly affects women. It is characterized by hypergammaglobulinemia, circulating autoantibodies, interface hepatitis on liver histology and a favourable response to immunosuppression. The putative mechanism for the development of autoimmune hepatitis is thought to be the interaction between genetic predisposition, environmental triggers and failure of the native immune system. AIH still remains a major diagnostic and therapeutic challenge, mainly because it is a very heterogeneous disease. Prompt and timely diagnosis is crucial since, if left untreated, AIH has a high mortality rate. Histological demonstration of hepatitis is required for the diagnosis of AIH and, therefore, liver biopsy is mandatory in the initial diagnostic work-up, before treatment. In this review, we summarize the histological features of AIH with the main aim of highlighting the most important clinical-pathological hallmarks useful in the routine diagnostic practice.

1 December 2019 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
SLSara Lemoinne
Sara Lemoinne
NCNora Cazzagon
Nora Cazzagon
SMSanaâ El Mouhadi
Sanaâ El Mouhadi
PTPalak J. Trivedi
Palak J. Trivedi
Anthony DohanAnthony Dohan
Anthony Dohan
LALionel Arrivé
Lionel Arrivé